ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    Cognition and Self-Management in Liver Transplant Recipients

    D. Ko,1 L. Bratzke,2 R. Muehrer.2

    1Vanderbilt University, Nashville; 2University of Wisconsin-Madison, Madison.

    Cognitive impairment in the liver transplant (LT) population could negatively affect one's ability to self-manage. This study examined cognition and its relationship with self-management in…
  • 2018 American Transplant Congress

    Acquired Resistance to Transplantation Tolerance as a Result of Prior Pregnancy Requires B Cells

    A. Suah,1 S. Khiew,1 J. Young,1 D. Yin,1 Q. Wang,1 M. Alegre,2 A. Chong.1

    1Surgery, Univeristy of Chicago Medicine, Chicago, IL; 2Medicine, University of Chicago, Chicago, IL.

    Introduction: Clinical data suggest allogeneic pregnancy is a sensitizing event; yet, recent data from mouse models indicates it induces fetal-specific regulatory T cell (Treg) expansion…
  • 2018 American Transplant Congress

    Respiratory Viral Infections Induces Exosomes and Antibodies to Lung Self-Antigens, Kα1Tubulin and Collagen V, Following Human Lung Transplantation

    M. Gunasekaran,1 S. Bansal,1 M. Sharma,1 R. Walia,1 R. Hachem,2 A. Limaye,3 R. Bremner,1 M. Smith,1 T. Mohanakumar.1

    1St. Joseph's Hosp & Med Ctr, Phoenix; 2Washington Univ Sch Med, St. Louis; 3Univ Washington, Seattle.

    Respiratory viral infection (RVI) following human lung transplantation (LTx) increases the risk for chronic rejection. We demonstrated that lung transplant recipients (LTxR) with acute and…
  • 2018 American Transplant Congress

    Impact of KDPI and CPRA on Outcomes in Kidney Transplant Recipients

    S. Sethi, R. Najjar, A. Peng, A. Vo, S. Jordan, E. Huang.

    Cedars Sinai Medical Center, Los Angeles.

    Introduction: The new KAS has led to a marked increase in kidney transplants among highly sensitized recipients, mostly attributable to higher allocation of low KDPI…
  • 2018 American Transplant Congress

    The Etiologies and Impact of Hospitalization in Older Kidney Transplant Recipients

    M. Posadas Salas, R. Rodriguez, P. Amaechi, V. Rao, D. Taber.

    Medical University of South Carolina, Charleston, SC.

    Older kidney transplant recipients (KTR) face challenges of post-transplant complications related to frailty and comorbidities. They are particularly vulnerable to infectious complications. This study elucidates…
  • 2018 American Transplant Congress

    The Risk Factors of Acute Rejection in Patients with BK Nephropathy after the Reduction of Immunosuppression

    C. Baek,1 H. Kim,1 W. Yang,1 D. Han,2 S-.K. Park.1

    1Department of Internal Medicine, Division of Nephrology, Asan Medical Center, Seoul, Republic of Korea; 2Department of Surgery, Asan Medical Center, Seoul, Republic of Korea.

    Background: BK nephropathy (BKN) affects graft function and increases the risk of graft failure. The reduction of immunosuppression is the main treatment for BKN. However,…
  • 2018 American Transplant Congress

    Cost Effectiveness of Lifelong Medicare Immunosuppressant Drug Coverage for Kidney Transplant Recipients in the Current Era

    M. Kadatz,1 J. Gill,2 J. Gill,2 K. Scott.3

    1Clinician Investigator Program, University of British Columbia, Vancouver, BC, Canada; 2Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada; 3Division of Nephrology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.

    While there is no Medicare time limit for dialysis patients, kidney transplant recipients lose their Medicare coverage 36 months after they receive their transplant. The…
  • 2018 American Transplant Congress

    Recipient IFNAR1 Signaling Supports Costimulation Independent Rejection by Promoting T Cell Activation

    D. Mathews, A. Ghosh, Y. Dong, K. Polireddy, A. Stephenson, C. Breeden, Y. Liu, A. Adams.

    Department of Surgery, Emory University, Atlanta, GA.

    Costimulation blockade (CoB) is a promising strategy for more targeted/less toxic transplant immunosuppression which has led to the first improvement in long-term outcomes for transplant…
  • 2018 American Transplant Congress

    Curative Correction of FAH Deficiency by Chimeric Stem Cells Transplantation

    D. Joo,1,2 E. Nelson,1 Y. Zhang,1 B. Amiot,1 S. Ho,3 C. Lancto,4 D. Carlson,4 L. Queiroz,5 S. Nyberg.1

    1Division of Transplant Surgery, Mayo Clinic, Rochester, MN; 2Department of Surgery, Yonsei University College of Medicine, Seoul, Korea; 3Department of Pathology, University of Michigan, Ann Arbor, MI; 4Recombinetics Inc, Saint Paul, MN; 5International Center for Biotechnology, Cooperative Resources International, Mount Horeb, WI.

    Fumarylacetoacetate hydrolase (FAH) deficient pigs have been proposed as surrogate hosts for large scale in vivo expansion of normal FAH+ hepatocytes. However, immunologic rejection prevents…
  • 2018 American Transplant Congress

    Follow Up of Patients Treated with the IgG Endopeptidase (IdeS) for Desensitization and HLA Incompatible (HLAi) Kidney Transplantation

    S. Jordan,1 J. Choi,1 E. Huang,1 R. Najjar,1 A. Peng,1 X. Zhang,1 S. Louie,1 M. Haas,2 S. Sethi,1 I. Kim,1 A. Vo.1

    1Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA; 2Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.

    Introduction:Donor-specific antibodies (DSAs) create an immunologic barrier to transplantation. This prevents transplantation for a significant percentage of highly-HLA sensitized patients (HS). Current desensitization therapies are…
  • « Previous Page
  • 1
  • …
  • 117
  • 118
  • 119
  • 120
  • 121
  • …
  • 211
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences